肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

敲除ASPP2可通过NF-κB途径促进小鼠DEN-诱导的肝癌发生

Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice 

原文发布日期:2021-02-08 

英文摘要:

摘要翻译: 

原文链接:

文章:

敲除ASPP2可通过NF-κB途径促进小鼠DEN-诱导的肝癌发生

Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice 

原文发布日期:2021-02-08 

英文摘要:

Apoptosis-stimulating protein p53 2 (ASPP2) is a member of the p53-binding protein family, which is closely related to tumor development. However, the precise mechanism of ASPP2 in liver inflammation and tumorigenesis remains largely unclear. We aimed to characterize the mechanistic significance and clinical implication of ASPP2 in hepatitis and hepatocellular carcinoma (HCC). In this study, ASPP2 knockout (APKO) mice were generated to confirm the role of ASPP2 in the development of hepatitis and HCC. Liver tissues from mice were analyzed by immunohistochemistry, Western blotting, proteomic analysis, ChIP-Seq, and qRT-PCR to evaluate the role of ASPP2 in DEN-induced hepatitis and HCC. We found that APKO promoted the formation of hepatitis/hepatocarcinoma and the increased expression of proinflammatory factors. The proteomics and Western blotting results showed that APKO activated the NF-κB signaling pathway. Further, ChIP-Seq results revealed that NF-κB target genes were dramatically increased in APKO mice. In contrast, blockade of the NF-κB pathway by QNZ reduced the expression of proinflammatory factors and the susceptibility of APKO mice to DEN-induced hepatocarcinogenesis. These results suggested that the absence of ASPP2 activates the NF-κB pathway to promote the occurrence of DEN-induced hepatocarcinogenesis, indicating that ASPP2 may be a potential target for the treatment of hepatocarcinoma. 

摘要翻译: 

凋亡刺激蛋白p53 2(ASPP2)是p53结合蛋白家族成员,与肿瘤发展密切相关。然而,ASPP2在肝脏炎症和肿瘤发生中的具体机制尚不明确。本研究旨在阐明ASPP2在肝炎和肝细胞癌(HCC)中的机制意义及临床价值。我们构建了ASPP2基因敲除(APKO)小鼠以验证其在肝炎和HCC发展中的作用,通过免疫组化、Western blotting、蛋白质组学分析、ChIP-Seq和qRT-PCR技术对小鼠肝组织进行分析,评估ASPP2在DEN诱导肝炎和HCC中的作用。研究发现APKO促进肝炎/肝癌形成并增强促炎因子表达。蛋白质组学和Western blotting结果表明APKO激活了NF-κB信号通路。ChIP-Seq结果进一步显示APKO小鼠中NF-κB靶基因显著增加。相反,使用QNZ阻断NF-κB通路可降低促炎因子表达,并减少APKO小鼠对DEN诱导肝癌发生的易感性。这些结果表明ASPP2缺失通过激活NF-κB通路促进DEN诱导的肝癌发生,提示ASPP2可能成为肝癌治疗的潜在靶点。

原文链接:

Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice 

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……